Eileen

SynaptiCure, Inc. is a neurology specialty telehealth clinic that provides personalized and convenient treatment for patients and caregivers with neurodegenerative diseases such as ALS, Parkinson's, Huntington's, Alzheimer's, and related dementias. The company is based in the United States and headquartered in an undisclosed location. SynaptiCure partners with health plans, providers, and community organizations to improve the lives of more than 10 million Americans living with neurodegenerative disease. The American company was founded in 2021 by an ALS patient and caregiver and offers quick and easy access to neurologists, behavioral health, care coordination, and additional services in one integrated care experience. The company was founded by Jonathan Hirsch, Jason M. Langheier, Brian Wallach, Martina de Majo, Sandra Abrevaya, Peter Wallach. Sandra Abrevaya has been the CEO since incorporation.